FIELD: pharmaceutical industry. SUBSTANCE: derivatives of 3(2H)-pyridazinone having formula are used for production of pharmaceutical composition. Said composition containing 0.5-95 mass % of mentioned above derivatives or their salts possesses inotropic, vasodilative activity. EFFECT: improves quality of desired product. 3 cl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 3(2H)-PYRIDAZINONES OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND PHARMACEUTICAL COMPOSITION ON SAID | 1994 |
|
RU2138486C1 |
METHOD OF SYNTHESIS OF IMIDAZO-(1,2-B)-PYRIDAZINE OR THEIR SALTS AND IMIDAZO-(1,2-B)-PYRIDAZINE DERIVATIVES OR THEIR SALTS | 1990 |
|
RU2036924C1 |
METHOD OF SYNTHESIS OF COMPOUNDS OF GROUP IMIDAZO-[1,2-B]-PYRIDAZINE OR THEIR SALT | 1991 |
|
RU2034846C1 |
INSECTICIDE COMPOSITION | 1988 |
|
RU2009642C1 |
DERIVATIVES OF 3(2H)-PYRIDAZINONE | 1992 |
|
RU2054422C1 |
PYRAZOLE GLYCOLIC ACID AMIDE DERIVATIVES, HERBICIDE COMPOSITION, METHOD OF WEED CONTROL | 1992 |
|
RU2090560C1 |
BENZIMIDAZOLE DERIVATIVE AND AGENT SHOWING ANTAGONISTIC ACTIVITY AGAINST SUBSTANCE P AND ANTIHISTAMINIC ACTIVITY | 1998 |
|
RU2188822C2 |
AGENT FOR TREATMENT OF ERECTILE FUNCTION | 1999 |
|
RU2229885C2 |
T-TYPE CALCIUM CHANNEL-BLOCKING AGENT | 2004 |
|
RU2326886C2 |
THERAPEUTIC AGENT FOR TREATMENT OF SPINAL CHANNEL STENOSIS | 1999 |
|
RU2229297C2 |
Authors
Dates
1996-02-10—Published
1991-04-19—Filed